Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015)

Kura Oncology (KURA) reported Long-Term Debt Issuances of $710000.0 for Q1 2015, down 64.5% quarter-over-quarter from $2.0 million in Q4 2014.

Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015) Analysis & Trends

Kura Oncology (KURA) has 5 years of Long-Term Debt Issuances data on file, last reported at $710000.0 in Q1 2015.

Long-Term Debt Issuances for Q1 2015 came in at $710000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $710000.0 (down 66.19% YoY), and the FY2022 annual result was $10.0 million, changed N/A from the prior year.
Long-Term Debt Issuances slipped to $710000.0 in Q1 2015 per KURA's latest filing, from $2.0 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $2.0 million in Q4 2014 and troughed at $25000.0 in Q1 2012.
A 4-year average of $572000.0 and a median of $100000.0 in 2014 frame the typical range for Long-Term Debt Issuances.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	2.73 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Kura Oncology	883.44 Mn	883.44 Mn	18.00 Mn	-

Download Data